+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hyperparathyroidism Market 2024-2028

  • PDF Icon

    Report

  • 206 Pages
  • October 2024
  • Region: Global
  • TechNavio
  • ID: 6020095
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The hyperparathyroidism market is forecasted to grow by USD 486.7 million during 2023-2028, accelerating at a CAGR of 7.1% during the forecast period. The report on the hyperparathyroidism market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in thyroid treatment awareness programs, growing focus on emerging economies, and increasing drug discovery.

The hyperparathyroidism market is segmented as below:

By Disease Type

  • Secondary hyperparathyroidism
  • Primary hyperparathyroidism
  • Tertiary hyperparathyroidism

By Distribution Channel

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing inorganic growth strategies among vendors as one of the prime reasons driving the hyperparathyroidism market growth during the next few years. Also, growing penetration of e-commerce for drug retail and rising clinical trials for hyperparathyroidism treatment will lead to sizable demand in the market.

The report on the hyperparathyroidism market covers the following areas:

  • Hyperparathyroidism Market sizing
  • Hyperparathyroidism Market forecast
  • Hyperparathyroidism Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hyperparathyroidism market vendors that include AbbVie Inc., Accord Healthcare Ltd., AdvaCare Pharma, Alkem Laboratories Ltd., Amgen Inc., Ascendis Pharma AS, Aurobindo Pharma Ltd., Biocon Ltd., Cipla Inc., Dr Reddys Laboratories Ltd., EA Pharma Co. Ltd., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Lupin Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd. Also, the hyperparathyroidism market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Disease Type
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
  • Overview on factors of disruption
2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
3.2 Market characteristics
  • Market characteristics analysis
3.3 Value chain analysis
  • Value Chain Analysis
4 Market Sizing
4.1 Market definition
  • Offerings of companies included in the market definition
4.2 Market segment analysis
  • Market segments
4.3 Market size 2023
4.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
5.1 Global Hyperparathyroidism Market 2018 - 2022
  • Historic Market Size - Data Table on Global Hyperparathyroidism Market 2018 - 2022 ($ million)
5.2 Disease Type segment analysis 2018 - 2022
  • Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
5.3 Distribution Channel segment analysis 2018 - 2022
  • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
5.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
6.1 The Impact of AI on Global Hyperparathyroidism Market
7 Five Forces Analysis
7.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
7.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Disease Type
8.1 Market segments
  • Chart on Disease Type - Market share 2023-2028 (%)
  • Data Table on Disease Type - Market share 2023-2028 (%)
8.2 Comparison by Disease Type
  • Chart on Comparison by Disease Type
  • Data Table on Comparison by Disease Type
8.3 Secondary hyperparathyroidism - Market size and forecast 2023-2028
  • Chart on Secondary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
  • Data Table on Secondary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
  • Chart on Secondary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
  • Data Table on Secondary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
8.4 Primary hyperparathyroidism - Market size and forecast 2023-2028
  • Chart on Primary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
  • Data Table on Primary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
  • Chart on Primary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
  • Data Table on Primary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
8.5 Tertiary hyperparathyroidism - Market size and forecast 2023-2028
  • Chart on Tertiary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
  • Data Table on Tertiary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
  • Chart on Tertiary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
  • Data Table on Tertiary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
8.6 Market opportunity by Disease Type
  • Market opportunity by Disease Type ($ million)
  • Data Table on Market opportunity by Disease Type ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
  • Chart on Distribution Channel - Market share 2023-2028 (%)
  • Data Table on Distribution Channel - Market share 2023-2028 (%)
9.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
9.3 Hospital pharmacy - Market size and forecast 2023-2028
  • Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
  • Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
9.4 Retail pharmacy - Market size and forecast 2023-2028
  • Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
  • Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  • Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
9.5 Online pharmacy - Market size and forecast 2023-2028
  • Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
  • Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
  • Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
9.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)
10 Customer Landscape
10.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
11.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
11.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
11.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
11.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
11.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
11.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
11.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
11.8 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
11.9 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
11.10 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
11.11 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
11.12 India - Market size and forecast 2023-2028
  • Chart on India - Market size and forecast 2023-2028 ($ million)
  • Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Chart on India - Year-over-year growth 2023-2028 (%)
  • Data Table on India - Year-over-year growth 2023-2028 (%)
11.13 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
11.14 Brazil - Market size and forecast 2023-2028
  • Chart on Brazil - Market size and forecast 2023-2028 ($ million)
  • Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
  • Chart on Brazil - Year-over-year growth 2023-2028 (%)
  • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
11.15 Italy - Market size and forecast 2023-2028
  • Chart on Italy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Italy - Market size and forecast 2023-2028 ($ million)
  • Chart on Italy - Year-over-year growth 2023-2028 (%)
  • Data Table on Italy - Year-over-year growth 2023-2028 (%)
11.16 South Korea - Market size and forecast 2023-2028
  • Chart on South Korea - Market size and forecast 2023-2028 ($ million)
  • Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
  • Chart on South Korea - Year-over-year growth 2023-2028 (%)
  • Data Table on South Korea - Year-over-year growth 2023-2028 (%)
11.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
  • Overview on factors of disruption
13.4 Industry risks
  • Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
  • Companies covered
14.2 Company ranking index
  • Company ranking index
14.3 Market positioning of companies
  • Matrix on companies position and classification
14.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • SWOT
14.5 Alkem Laboratories Ltd.
  • Alkem Laboratories Ltd. - Overview
  • Alkem Laboratories Ltd. - Business segments
  • Alkem Laboratories Ltd. - Key offerings
  • Alkem Laboratories Ltd. - Segment focus
  • SWOT
14.6 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key news
  • Amgen Inc. - Key offerings
  • SWOT
14.7 Aurobindo Pharma Ltd.
  • Aurobindo Pharma Ltd. - Overview
  • Aurobindo Pharma Ltd. - Product / Service
  • Aurobindo Pharma Ltd. - Key offerings
  • SWOT
14.8 Biocon Ltd.
  • Biocon Ltd. - Overview
  • Biocon Ltd. - Business segments
  • Biocon Ltd. - Key offerings
  • Biocon Ltd. - Segment focus
  • SWOT
14.9 Cipla Inc.
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key news
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Segment focus
  • SWOT
14.10 Dr Reddys Laboratories Ltd.
  • Dr Reddys Laboratories Ltd. - Overview
  • Dr Reddys Laboratories Ltd. - Business segments
  • Dr Reddys Laboratories Ltd. - Key news
  • Dr Reddys Laboratories Ltd. - Key offerings
  • Dr Reddys Laboratories Ltd. - Segment focus
  • SWOT
14.11 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
14.12 Fresenius SE and Co. KGaA
  • Fresenius SE and Co. KGaA - Overview
  • Fresenius SE and Co. KGaA - Business segments
  • Fresenius SE and Co. KGaA - Key news
  • Fresenius SE and Co. KGaA - Key offerings
  • Fresenius SE and Co. KGaA - Segment focus
  • SWOT
14.13 Lupin Ltd.
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Business segments
  • Lupin Ltd. - Key news
  • Lupin Ltd. - Key offerings
  • Lupin Ltd. - Segment focus
  • SWOT
14.14 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT
14.15 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
  • SWOT
14.16 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus
  • SWOT
14.17 Viatris Inc.
  • Viatris Inc. - Overview
  • Viatris Inc. - Business segments
  • Viatris Inc. - Key news
  • Viatris Inc. - Key offerings
  • Viatris Inc. - Segment focus
  • SWOT
14.18 Zydus Lifesciences Ltd.
  • Zydus Lifesciences Ltd. - Overview
  • Zydus Lifesciences Ltd. - Business segments
  • Zydus Lifesciences Ltd. - Key news
  • Zydus Lifesciences Ltd. - Key offerings
  • Zydus Lifesciences Ltd. - Segment focus
  • SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
15.4 Research methodology
  • Research methodology
15.5 Data procurement
  • Information sources
15.6 Data validation
  • Data validation
15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
15.8 Data synthesis
  • Data synthesis
15.9 360 degree market analysis
  • 360 degree market analysis
15.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 11: Overview on criticality of inputs and factors of differentiation
Exhibits 12: Overview on factors of disruption
Exhibits 13: Impact of drivers and challenges in 2023 and 2028
Exhibits 14: Parent Market
Exhibits 15: Data Table on - Parent Market
Exhibits 16: Market characteristics analysis
Exhibits 17: Value Chain Analysis
Exhibits 18: Offerings of companies included in the market definition
Exhibits 19: Market segments
Exhibits 20: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 21: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 22: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 23: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 24: Historic Market Size - Data Table on Global Hyperparathyroidism Market 2018 - 2022 ($ million)
Exhibits 25: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
Exhibits 26: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits 27: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 28: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 29: Five forces analysis - Comparison between 2023 and 2028
Exhibits 30: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 31: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 32: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 33: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 34: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 35: Chart on Market condition - Five forces 2023 and 2028
Exhibits 36: Chart on Disease Type - Market share 2023-2028 (%)
Exhibits 37: Data Table on Disease Type - Market share 2023-2028 (%)
Exhibits 38: Chart on Comparison by Disease Type
Exhibits 39: Data Table on Comparison by Disease Type
Exhibits 40: Chart on Secondary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Secondary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Secondary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Secondary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Primary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on Primary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on Primary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Primary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
Exhibits 48: Chart on Tertiary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Tertiary hyperparathyroidism - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Tertiary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Tertiary hyperparathyroidism - Year-over-year growth 2023-2028 (%)
Exhibits 52: Market opportunity by Disease Type ($ million)
Exhibits 53: Data Table on Market opportunity by Disease Type ($ million)
Exhibits 54: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 55: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 56: Chart on Comparison by Distribution Channel
Exhibits 57: Data Table on Comparison by Distribution Channel
Exhibits 58: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 66: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 69: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 70: Market opportunity by Distribution Channel ($ million)
Exhibits 71: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 73: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 74: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 75: Chart on Geographic comparison
Exhibits 76: Data Table on Geographic comparison
Exhibits 77: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 109: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 110: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 111: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 112: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 113: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits 114: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits 115: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits 116: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits 117: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 118: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 119: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 120: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 121: Chart on Brazil - Market size and forecast 2023-2028 ($ million)
Exhibits 122: Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
Exhibits 123: Chart on Brazil - Year-over-year growth 2023-2028 (%)
Exhibits 124: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
Exhibits 125: Chart on Italy - Market size and forecast 2023-2028 ($ million)
Exhibits 126: Data Table on Italy - Market size and forecast 2023-2028 ($ million)
Exhibits 127: Chart on Italy - Year-over-year growth 2023-2028 (%)
Exhibits 128: Data Table on Italy - Year-over-year growth 2023-2028 (%)
Exhibits 129: Chart on South Korea - Market size and forecast 2023-2028 ($ million)
Exhibits 130: Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
Exhibits 131: Chart on South Korea - Year-over-year growth 2023-2028 (%)
Exhibits 132: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
Exhibits 133: Market opportunity By Geographical Landscape ($ million)
Exhibits 134: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 135: Impact of drivers and challenges in 2023 and 2028
Exhibits 136: Overview on criticality of inputs and factors of differentiation
Exhibits 137: Overview on factors of disruption
Exhibits 138: Impact of key risks on business
Exhibits 139: Companies covered
Exhibits 140: Company ranking index
Exhibits 141: Matrix on companies position and classification
Exhibits 142: AbbVie Inc. - Overview
Exhibits 143: AbbVie Inc. - Product / Service
Exhibits 144: AbbVie Inc. - Key news
Exhibits 145: AbbVie Inc. - Key offerings
Exhibits 146: SWOT
Exhibits 147: Alkem Laboratories Ltd. - Overview
Exhibits 148: Alkem Laboratories Ltd. - Business segments
Exhibits 149: Alkem Laboratories Ltd. - Key offerings
Exhibits 150: Alkem Laboratories Ltd. - Segment focus
Exhibits 151: SWOT
Exhibits 152: Amgen Inc. - Overview
Exhibits 153: Amgen Inc. - Product / Service
Exhibits 154: Amgen Inc. - Key news
Exhibits 155: Amgen Inc. - Key offerings
Exhibits 156: SWOT
Exhibits 157: Aurobindo Pharma Ltd. - Overview
Exhibits 158: Aurobindo Pharma Ltd. - Product / Service
Exhibits 159: Aurobindo Pharma Ltd. - Key offerings
Exhibits 160: SWOT
Exhibits 161: Biocon Ltd. - Overview
Exhibits 162: Biocon Ltd. - Business segments
Exhibits 163: Biocon Ltd. - Key offerings
Exhibits 164: Biocon Ltd. - Segment focus
Exhibits 165: SWOT
Exhibits 166: Cipla Inc. - Overview
Exhibits 167: Cipla Inc. - Business segments
Exhibits 168: Cipla Inc. - Key news
Exhibits 169: Cipla Inc. - Key offerings
Exhibits 170: Cipla Inc. - Segment focus
Exhibits 171: SWOT
Exhibits 172: Dr Reddys Laboratories Ltd. - Overview
Exhibits 173: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 174: Dr Reddys Laboratories Ltd. - Key news
Exhibits 175: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 176: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 177: SWOT
Exhibits 178: F. Hoffmann La Roche Ltd. - Overview
Exhibits 179: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 180: F. Hoffmann La Roche Ltd. - Key news
Exhibits 181: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 182: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 183: SWOT
Exhibits 184: Fresenius SE and Co. KGaA - Overview
Exhibits 185: Fresenius SE and Co. KGaA - Business segments
Exhibits 186: Fresenius SE and Co. KGaA - Key news
Exhibits 187: Fresenius SE and Co. KGaA - Key offerings
Exhibits 188: Fresenius SE and Co. KGaA - Segment focus
Exhibits 189: SWOT
Exhibits 190: Lupin Ltd. - Overview
Exhibits 191: Lupin Ltd. - Business segments
Exhibits 192: Lupin Ltd. - Key news
Exhibits 193: Lupin Ltd. - Key offerings
Exhibits 194: Lupin Ltd. - Segment focus
Exhibits 195: SWOT
Exhibits 196: Sanofi SA - Overview
Exhibits 197: Sanofi SA - Business segments
Exhibits 198: Sanofi SA - Key news
Exhibits 199: Sanofi SA - Key offerings
Exhibits 200: Sanofi SA - Segment focus
Exhibits 201: SWOT
Exhibits 202: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 203: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 204: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 205: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 206: SWOT
Exhibits 207: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 208: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 209: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 210: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 211: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 212: SWOT
Exhibits 213: Viatris Inc. - Overview
Exhibits 214: Viatris Inc. - Business segments
Exhibits 215: Viatris Inc. - Key news
Exhibits 216: Viatris Inc. - Key offerings
Exhibits 217: Viatris Inc. - Segment focus
Exhibits 218: SWOT
Exhibits 219: Zydus Lifesciences Ltd. - Overview
Exhibits 220: Zydus Lifesciences Ltd. - Business segments
Exhibits 221: Zydus Lifesciences Ltd. - Key news
Exhibits 222: Zydus Lifesciences Ltd. - Key offerings
Exhibits 223: Zydus Lifesciences Ltd. - Segment focus
Exhibits 224: SWOT
Exhibits 225: Inclusions checklist
Exhibits 226: Exclusions checklist
Exhibits 227: Currency conversion rates for US$
Exhibits 228: Research methodology
Exhibits 229: Information sources
Exhibits 230: Data validation
Exhibits 231: Validation techniques employed for market sizing
Exhibits 232: Data synthesis
Exhibits 233: 360 degree market analysis
Exhibits 234: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global hyperparathyroidism market: AbbVie Inc., Accord Healthcare Ltd., AdvaCare Pharma, Alkem Laboratories Ltd., Amgen Inc., Ascendis Pharma AS, Aurobindo Pharma Ltd., Biocon Ltd., Cipla Inc., Dr Reddys Laboratories Ltd., EA Pharma Co. Ltd., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Lupin Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing inorganic growth strategies among vendors."

According to the report, one of the major drivers for this market is the rise in thyroid treatment awareness programs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Accord Healthcare Ltd.
  • AdvaCare Pharma
  • Alkem Laboratories Ltd.
  • Amgen Inc.
  • Ascendis Pharma AS
  • Aurobindo Pharma Ltd.
  • Biocon Ltd.
  • Cipla Inc.
  • Dr Reddys Laboratories Ltd.
  • EA Pharma Co. Ltd.
  • F. Hoffmann La Roche Ltd.
  • Fresenius SE and Co. KGaA
  • Lupin Ltd.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zydus Lifesciences Ltd.

Related Topics

Related Reports

Hypoparathyroidism Market 2024-2028 - Product Image

Hypoparathyroidism Market 2024-2028

  • Report
  • 202 Pages
  • Global
From
Thyroid Gland Disorder Treatment Market 2024-2028 - Product Image

Thyroid Gland Disorder Treatment Market 2024-2028

  • Report
  • 163 Pages
  • Global
From
Hyperparathyroidism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Hyperparathyroidism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 132 Pages
  • Global
From
Secondary Hyperparathyroidism Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Secondary Hyperparathyroidism Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 186 Pages
  • Global
From
Hyperparathyroidism - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Hyperparathyroidism - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.